Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers.

Eeckhoute J, Lupien M, Meyer CA, Verzi MP, Shivdasani RA, Liu XS, Brown M.

Genome Res. 2009 Mar;19(3):372-80. doi: 10.1101/gr.084582.108. Epub 2009 Jan 7.

2.

Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers.

Sérandour AA, Avner S, Percevault F, Demay F, Bizot M, Lucchetti-Miganeh C, Barloy-Hubler F, Brown M, Lupien M, Métivier R, Salbert G, Eeckhoute J.

Genome Res. 2011 Apr;21(4):555-65. doi: 10.1101/gr.111534.110. Epub 2011 Jan 13.

3.

FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription.

Lupien M, Eeckhoute J, Meyer CA, Wang Q, Zhang Y, Li W, Carroll JS, Liu XS, Brown M.

Cell. 2008 Mar 21;132(6):958-70. doi: 10.1016/j.cell.2008.01.018.

4.

Foxa1 functions as a pioneer transcription factor at transposable elements to activate Afp during differentiation of embryonic stem cells.

Taube JH, Allton K, Duncan SA, Shen L, Barton MC.

J Biol Chem. 2010 May 21;285(21):16135-44. doi: 10.1074/jbc.M109.088096. Epub 2010 Mar 26.

5.

FOXA1 potentiates lineage-specific enhancer activation through modulating TET1 expression and function.

Yang YA, Zhao JC, Fong KW, Kim J, Li S, Song C, Song B, Zheng B, He C, Yu J.

Nucleic Acids Res. 2016 Sep 30;44(17):8153-64. doi: 10.1093/nar/gkw498. Epub 2016 Jun 1.

6.

FOXA1 defines cancer cell specificity.

Zhang G, Zhao Y, Liu Y, Kao LP, Wang X, Skerry B, Li Z.

Sci Adv. 2016 Mar 18;2(3):e1501473. doi: 10.1126/sciadv.1501473. eCollection 2016 Mar.

7.

Establishment of active chromatin structure at enhancer elements by mixed-lineage leukemia 1 to initiate estrogen-dependent gene expression.

Jeong KW, Andreu-Vieyra C, You JS, Jones PA, Stallcup MR.

Nucleic Acids Res. 2014 Feb;42(4):2245-56. doi: 10.1093/nar/gkt1236. Epub 2013 Nov 27.

8.

Chromatin remodeling mediated by the FOXA1/A2 transcription factors activates CFTR expression in intestinal epithelial cells.

Kerschner JL, Gosalia N, Leir SH, Harris A.

Epigenetics. 2014 Apr;9(4):557-65. doi: 10.4161/epi.27696. Epub 2014 Jan 17.

9.

Epigenetic priming of enhancers predicts developmental competence of hESC-derived endodermal lineage intermediates.

Wang A, Yue F, Li Y, Xie R, Harper T, Patel NA, Muth K, Palmer J, Qiu Y, Wang J, Lam DK, Raum JC, Stoffers DA, Ren B, Sander M.

Cell Stem Cell. 2015 Apr 2;16(4):386-99. doi: 10.1016/j.stem.2015.02.013.

10.

GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility.

Theodorou V, Stark R, Menon S, Carroll JS.

Genome Res. 2013 Jan;23(1):12-22. doi: 10.1101/gr.139469.112. Epub 2012 Nov 21.

11.

SNAIL1-mediated downregulation of FOXA proteins facilitates the inactivation of transcriptional enhancer elements at key epithelial genes in colorectal cancer cells.

Jägle S, Busch H, Freihen V, Beyes S, Schrempp M, Boerries M, Hecht A.

PLoS Genet. 2017 Nov 20;13(11):e1007109. doi: 10.1371/journal.pgen.1007109. eCollection 2017 Nov.

12.

NFI transcription factors interact with FOXA1 to regulate prostate-specific gene expression.

Grabowska MM, Elliott AD, DeGraff DJ, Anderson PD, Anumanthan G, Yamashita H, Sun Q, Friedman DB, Hachey DL, Yu X, Sheehan JH, Ahn JM, Raj GV, Piston DW, Gronostajski RM, Matusik RJ.

Mol Endocrinol. 2014 Jun;28(6):949-64. doi: 10.1210/me.2013-1213. Epub 2014 May 6.

13.

TP53 engagement with the genome occurs in distinct local chromatin environments via pioneer factor activity.

Sammons MA, Zhu J, Drake AM, Berger SL.

Genome Res. 2015 Feb;25(2):179-88. doi: 10.1101/gr.181883.114. Epub 2014 Nov 12.

14.

Genome-wide analysis reveals positional-nucleosome-oriented binding pattern of pioneer factor FOXA1.

Ye Z, Chen Z, Sunkel B, Frietze S, Huang TH, Wang Q, Jin VX.

Nucleic Acids Res. 2016 Sep 19;44(16):7540-54. doi: 10.1093/nar/gkw659. Epub 2016 Jul 25.

15.

FoxA1 and glucocorticoid receptor crosstalk via histone H4K16 acetylation at a hormone regulated enhancer.

Belikov S, Holmqvist PH, Astrand C, Wrange Ö.

Exp Cell Res. 2012 Jan 1;318(1):61-74. doi: 10.1016/j.yexcr.2011.09.016. Epub 2011 Oct 6.

PMID:
22001115
16.

Bookmarking by specific and nonspecific binding of FoxA1 pioneer factor to mitotic chromosomes.

Caravaca JM, Donahue G, Becker JS, He X, Vinson C, Zaret KS.

Genes Dev. 2013 Feb 1;27(3):251-60. doi: 10.1101/gad.206458.112. Epub 2013 Jan 25.

17.

FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3.

Jozwik KM, Chernukhin I, Serandour AA, Nagarajan S, Carroll JS.

Cell Rep. 2016 Dec 6;17(10):2715-2723. doi: 10.1016/j.celrep.2016.11.028.

18.

The chromatin Remodeler CHD8 is required for activation of progesterone receptor-dependent enhancers.

Ceballos-Chávez M, Subtil-Rodríguez A, Giannopoulou EG, Soronellas D, Vázquez-Chávez E, Vicent GP, Elemento O, Beato M, Reyes JC.

PLoS Genet. 2015 Apr 20;11(4):e1005174. doi: 10.1371/journal.pgen.1005174. eCollection 2015 Apr.

19.

High-throughput RNA FISH analysis by imaging flow cytometry reveals that pioneer factor Foxa1 reduces transcriptional stochasticity.

Lalmansingh AS, Arora K, Demarco RA, Hager GL, Nagaich AK.

PLoS One. 2013 Sep 20;8(9):e76043. doi: 10.1371/journal.pone.0076043. eCollection 2013.

20.

Unique ERalpha cistromes control cell type-specific gene regulation.

Krum SA, Miranda-Carboni GA, Lupien M, Eeckhoute J, Carroll JS, Brown M.

Mol Endocrinol. 2008 Nov;22(11):2393-406. doi: 10.1210/me.2008-0100. Epub 2008 Sep 25.

Supplemental Content

Support Center